Department of Stomatology II, University of the Basque Country (EHU), Leioa, Spain.
Oral Medicine, Oral Surgery and Implantology Unit (MedOralRes Group), Faculty of Medicine and Dentistry, University of Santiago de Compostela, Santiago de Compostela, A Coruña, Spain.
J Oral Pathol Med. 2022 Jan;51(1):30-38. doi: 10.1111/jop.13246. Epub 2021 Oct 13.
Proliferative verrucous/multifocal leukoplakia (PVML) is an oral potentially malignant disorder (OPMD) that exhibits high rates of malignant development (MD). This study aimed to analyse the risk of MD of PVML, as well as to investigate the possible risk factors associated with its malignization.
A bibliographical search of the PubMed, Embase, Web of Science, and Scopus databases was conducted. PVML MD rates were calculated as a pooled proportion, and the risk factors were calculated as risk ratios, using fixed and random models based on the presence of heterogeneity.
From a total of 417 records, 16 articles were retrieved for inclusion. The subgroup analysis revealed a higher MD rate in the studies that were conducted in America, and, likewise, said studies involved a longer follow-up time (>6 years). There was a non-significant lower risk of malignization among males. A negative correlation was observed between MD and the year in which the studies were published.
The pooled MD of PVML was 65.8% (95% CI: 55.3-76.2, p < 0.001). Prospective studies of PVML must be designed using simple and universal clinical diagnostic criteria to be able to make an early diagnosis of this important OPMD and acknowledge the frequency of MD.
增殖性疣状/多灶性白斑(PVML)是一种口腔潜在恶性疾病(OPMD),具有较高的恶性发展(MD)率。本研究旨在分析 PVML 的 MD 风险,并探讨与其恶变相关的可能危险因素。
对 PubMed、Embase、Web of Science 和 Scopus 数据库进行文献检索。采用固定和随机模型,根据异质性的存在情况,计算 PVML MD 率的合并比例和危险因素的风险比。
从总共 417 条记录中检索到 16 篇文章进行纳入。亚组分析显示,在美国进行的研究中 MD 率更高,同样,这些研究的随访时间也更长(>6 年)。男性恶变的风险较低,但无统计学意义。MD 与研究发表年份之间呈负相关。
PVML 的 MD 总发生率为 65.8%(95%CI:55.3-76.2,p<0.001)。必须使用简单和通用的临床诊断标准设计针对 PVML 的前瞻性研究,以便能够早期诊断这种重要的 OPMD,并认识到 MD 的频率。